Clinical Trial Details


Back to Clinical Trials Database

Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 08-Apr-2003
Date Step1 close: 25-May-2010
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 450
Treatment Doxorubicin, Ifosfamide
Study Staff
Type of cancer
Participating groups EORTC Soft Tissue and Bone Sarcoma Group
NCIC Clinical Trial Group
Protocol summary
NCT number NCT00061984
EudraCT 2004-002113-36